NVObenzinga

Novo Nordisk 2024 Outlook, Updated: Now Expects Sales Growth Of 23%-27% (Prior 22%-28%) And Operating Profit Growth Of 21%-27% (Prior 20%-28%)

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 6, 2024 by benzinga